Lumida
/GLSI
⌘K
Greenwich Lifesciences Inc

Greenwich Lifesciences Inc

GLSI
$16.32USD-14.15%-2.69 today

MARKET CAP

239.5M

P/E (TTM)

FWD P/E

DAY RANGE

$16 – $19

52W RANGE

$8
$34

AI Summary

Stalk
TrimMedium

GLSI remains entrenched in a Stage 4 decline following a decisive Support Failure. Price is extended into extreme oversold conditions but has only staged a bounce up to yet-unretested overhead EMAs. The medium-term bias is bearish, and preferred execution is deferred sell-side engagement on rallies into the declining 9/21 EMAs and 50 DMA rather than chasing current weakness.

  • European approval for GP2 in Phase III FLAMINGO-01 trial announced Jul 2026 drives stock catalyst
  • Momentum factor indicates strong price trends, fueling investor interest
  • Volatility multiplier of 4.53 signals extreme price swings deterring risk-averse investors
Full analysis →
Insider Trades47 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jan 13, 2026BuyGLSISnehal PatelCEO and CFO1,800$29.83$239.5M-52.14%+109.77%$53.7K+0.03%Trim
Jan 12, 2026BuyGLSISnehal PatelCEO and CFO2,900$27.54$239.5M-52.14%+109.77%$79.9K+0.05%Trim
Dec 31, 2025BuyGLSISnehal PatelCEO and CFO4,300$21.36$239.5M-52.14%+109.77%$91.8K+0.08%Trim
Dec 30, 2025BuyGLSISnehal PatelCEO and CFO2,900$21.73$239.5M-52.14%+109.77%$63.0K+0.05%Trim
Dec 18, 2025BuyGLSISnehal PatelCEO and CFO4,100$12.62$239.5M-52.14%+109.77%$51.7K+0.07%Trim
Nov 25, 2025BuyGLSISnehal PatelCEO and CFO4,600$8.37$239.5M-52.14%+109.77%$38.5K+0.08%Trim
Nov 7, 2025BuyGLSISnehal PatelCEO and CFO10,600$8.43$239.5M-52.14%+109.77%$89.4K+0.19%Trim
Oct 31, 2025BuyGLSISnehal PatelCEO and CFO2,300$9.26$239.5M-52.14%+109.77%$21.3K+0.04%Trim
Apr 25, 2025BuyGLSISnehal PatelCEO and CFO3,600$9.88$239.5M-52.14%+109.77%$35.6K+0.06%Trim
Apr 17, 2025BuyGLSISnehal PatelCEO and CFO5,400$8.98$239.5M-52.14%+109.77%$48.5K+0.10%Trim
Apr 7, 2025BuyGLSISnehal PatelCEO and CFO3,600$9.10$239.5M-52.14%+109.77%$32.8K+0.06%Trim
Apr 4, 2025BuyGLSISnehal PatelCEO and CFO5,500$8.73$239.5M-52.14%+109.77%$48.0K+0.10%Trim
Jan 10, 2025BuyGLSISnehal PatelCEO and CFO2,500$12.51$239.5M-52.14%+109.77%$31.3K+0.05%Trim
Jan 6, 2025BuyGLSISnehal PatelCEO and CFO2,900$13.58$239.5M-52.14%+109.77%$39.4K+0.03%Trim
Jan 3, 2025BuyGLSISnehal PatelCEO and CFO3,400$12.95$239.5M-52.14%+109.77%$44.0K+0.06%Trim
Jan 2, 2025BuyGLSISnehal PatelCEO and CFO2,000$11.97$239.5M-52.14%+109.77%$23.9K+0.04%Trim
Dec 31, 2024BuyGLSISnehal PatelCEO and CFO2,400$11.36$239.5M-52.14%+109.77%$27.3K+0.04%Trim
Dec 30, 2024BuyGLSISnehal PatelCEO and CFO3,200$11.12$239.5M-52.14%+109.77%$35.6K+0.06%Trim
Nov 21, 2024BuyGLSIJaye ThompsonVP Clinical Reg Affairs1,000$12.91$239.5M-52.14%+109.77%$12.9K+0.38%Trim
Sep 26, 2024BuyGLSISnehal PatelCEO and CFO1,500$14.63$239.5M-52.14%+109.77%$21.9K+0.03%Trim
Aug 12, 2024BuyGLSIJaye ThompsonVP Clinical Reg Affairs800$13.85$239.5M-52.14%+109.77%$11.1K+0.30%Trim
Aug 6, 2024BuyGLSISnehal PatelCEO and CFO2,000$13.81$239.5M-52.14%+109.77%$27.6K+0.04%Trim
Aug 5, 2024BuyGLSISnehal PatelCEO and CFO5,500$13.18$239.5M-52.14%+109.77%$72.5K+0.10%Trim
Aug 2, 2024BuyGLSIJaye ThompsonVP Clinical Reg Affairs1,000$15.15$239.5M-52.14%+109.77%$15.2K+0.38%Trim
Jul 23, 2024BuyGLSISnehal PatelCEO and CFO1,500$15.89$239.5M-52.14%+109.77%$23.8K+0.03%Trim
Jul 18, 2024BuyGLSIJaye ThompsonVP Clinical Reg Affairs1,000$16.00$239.5M-52.14%+109.77%$16.0K+0.38%Trim
Jun 13, 2024BuyGLSISnehal PatelCEO and CFO174,825$14.30$239.5M-52.14%+109.77%$2.5M+3.27%Trim
Apr 1, 2024BuyGLSISnehal PatelCEO and CFO3,000$19.08$239.5M-52.14%+109.77%$57.2K+0.06%Trim
Mar 22, 2024BuyGLSISnehal PatelCEO and CFO2,500$19.98$239.5M-52.14%+109.77%$50.0K+0.05%Trim
Mar 20, 2024BuyGLSISnehal PatelCEO and CFO1,500$17.68$239.5M-52.14%+109.77%$26.5K+0.03%Trim
Mar 5, 2024BuyGLSISnehal PatelCEO and CFO3,500$12.49$239.5M-52.14%+109.77%$43.7K+0.07%Trim
Mar 5, 2024BuyGLSISnehal PatelCEO and CFO30,500$12.49$239.5M-52.14%+109.77%$380.9K+0.57%Trim
Mar 4, 2024BuyGLSISnehal PatelCEO and CFO4,100$13.03$239.5M-52.14%+109.77%$53.4K+0.08%Trim
Feb 16, 2024BuyGLSISnehal PatelCEO and CFO10,800$11.16$239.5M-52.14%+109.77%$120.5K+0.20%Trim
Feb 15, 2024BuyGLSISnehal PatelCEO and CFO12,700$11.07$239.5M-52.14%+109.77%$140.6K+0.24%Trim
Nov 10, 2023BuyGLSISnehal PatelCEO and CFO5,000$10.17$239.5M-52.14%+109.77%$50.8K+0.09%Trim
Nov 3, 2023BuyGLSISnehal PatelCEO and CFO3,500$9.11$239.5M-52.14%+109.77%$31.9K+0.07%Trim
Oct 27, 2023BuyGLSIJaye ThompsonVP Clinical Reg Affairs500$8.57$239.5M-52.14%+109.77%$4.3K+0.19%Trim
Oct 26, 2023BuyGLSISnehal PatelCEO and CFO2,500$7.97$239.5M-52.14%+109.77%$19.9K+0.05%Trim
Oct 25, 2023BuyGLSISnehal PatelCEO and CFO2,500$7.91$239.5M-52.14%+109.77%$19.8K+0.05%Trim
Oct 10, 2023BuyGLSISnehal PatelCEO and CFO1,000$9.07$239.5M-52.14%+109.77%$9.1K+0.02%Trim
Oct 4, 2023BuyGLSISnehal PatelCEO and CFO2,000$8.63$239.5M-52.14%+109.77%$17.3K+0.04%Trim
Sep 26, 2023BuyGLSIJaye ThompsonVP Clinical Reg Affairs600$8.71$239.5M-52.14%+109.77%$5.2K+0.23%Trim
Sep 19, 2023BuyGLSISnehal PatelCEO and CFO4,000$8.95$239.5M-52.14%+109.77%$35.8K+0.08%Trim
Sep 11, 2023BuyGLSISnehal PatelCEO and CFO1,000$9.48$239.5M-52.14%+109.77%$9.5K+0.02%Trim
Aug 22, 2023BuyGLSISnehal PatelCEO and CFO1,000$9.97$239.5M-52.14%+109.77%$10.0K+0.02%Trim
Aug 4, 2023BuyGLSISnehal PatelCEO and CFO2,000$10.55$239.5M-52.14%+109.77%$21.1K+0.04%Trim